Podcasts about Drug

Federal government moves to ban apps that create nude deepfake images of children Search for alleged police killer in Victoria's high country enters its second week Drug kingpin Tony Mokbel returns to court to overturn convictions And Gen Z battle refuel anxiety at the pumpSee omnystudio.com/listener for privacy information.

The US government has a long history of supporting corrupt, drug-dealing, right-wing oligarchs in Latin America. The Donald Trump administration is threatening to attack Venezuela, accusing leftist President Nicolás Maduro, without any evidence, of leading a cartel, while Marco Rubio defends Colombia's drug-trafficking former leader Álvaro Uribe. Ben Norton documents Washington's imperial hypocrisy. VIDEO: https://www.youtube.com/watch?v=JwCducQ8HHw Topics 0:00 Hypocritical US meddling in Latin America 1:41 Colombia's ex President Álvaro Uribe 4:52 (CLIP) CIA director: "We lie, cheat, steal" 5:09 Drug cartels linked to Colombian leader 6:49 Paramilitaries linked to Colombian leader 9:16 False positives scandal 11:36 Plan Colombia 12:37 Left-wing President Gustavo Petro 14:55 US interventions in Latin America 15:39 Honduran dictator Juan Orlando Hernández (JOH) 16:48 US-backed coup in Honduras in 2009 18:27 US support for dictators 19:41 Drug trafficking in Honduras 22:36 US foreign policy in Latin America 22:59 CIA-backed Nicaraguan Contras 24:09 Trump admin attacks Venezuela (again) 25:50 Outro

A clinical trial has demonstrated that an existing constipation drug called lubiprostone helps slow the progression of chronic kidney disease, a Japanese research team said.

RFK Jr. has launched an investigation to see if drugs taken by trans shooter Robin Westman AND OTHER school shooters may have played a role in the horrific attack.See omnystudio.com/listener for privacy information.

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Senior Editor Sue Sutter discuss the impact of US Food and Drug Administration's COVID-19 vaccine indication changes and recission of the associated emergency use authorizations, as well as the postmarketing studies that now are required (:40), and their potential impact on access and reimbursement (12:20). More On These Topics From The Pink Sheet COVID-19 Vaccines: Pfizer Arguments To Keep EUA Failed To Persuade US FDA's Prasad: https://insights.citeline.com/pink-sheet/vaccines/covid-19-vaccines-pfizer-arguments-to-keep-eua-failed-to-persuade-us-fdas-prasad-V3X2OEBZE5HRHKO7KMMCFXBM2Q/ US FDA Updates COVID-19 Vaccine Formulations, Revokes EUAs, ACIP Use Decision Next: https://insights.citeline.com/pink-sheet/vaccines/us-fda-updates-covid-19-vaccine-formulations-revokes-euas-acip-use-decision-next-VBXJDSOA6BCOXNCA2TAH27EBJY/ A US FDA Move to Revoke Pfizer's Pediatric COVID-19 Vaccine EUA Could Raise Supply Questions: https://insights.citeline.com/pink-sheet/vaccines/a-us-fda-move-to-revoke-pfizers-pediatric-covid-19-vaccine-eua-could-raise-supply-questions-ZX26DBENHFCOHPBGMPFPQB6REQ/ Changes In Pediatric COVID-19 Vaccine Recommendations Causing Coverage Confusion: https://insights.citeline.com/pink-sheet/vaccines/changes-in-pediatric-covid-19-vaccine-recommendations-causing-coverage-confusion-WDEYUVJXGBCGBEVBQ2I6INH554/

As we head into Labor Day weekend, I'm flexing one of my superpowers: organizing information.   In this episode of The Pharmacist's Voice Podcast, I share the story behind my book binder — a simple but powerful system that helps me keep track of dozens of book recommendations and the 20–30 books I read each year. You'll hear how I went from barely finding time to read as a busy mom to becoming an audiobook enthusiast with a binder full of possibilities.   I'll also share 26 books currently on my “to be read” list (plus the Spy School series I'm enjoying with my son Kraig). Maybe you'll discover your next great read from this podcast episode!   Even if books aren't your thing, you'll walk away with this takeaway: what makes you weird might actually be your superpower. For me, it's organizing information. For you, it could be something else entirely — and when you embrace it, life gets easier, less stressful, and more fun. You just might help other people too!  

On episode 138 of PSQH: The Podcast, Karen Kobelski, Vice President and General Manager for Clinical Surveillance, Compliance & Data Solutions at Wolters Kluwer Health, discusses the current state of drug diversion in healthcare.

Send us a text00:00:00 - Surf's Up, Season 6, Episode 12This week's episode is a special three-part roundtable on the implications of the FDA's recent approval of semaglutide. Naim Alkhouri, Manal Abdelmalek, Scott Isaacs and Zobair Younossi join Roger Green in a discussion that focuses less on specifics of pharmacotherapy and more on how having two drugs available will change MASH management in the US.00:08:45 - Part I: How Will The Semaglutide Approval Affect Patient Treatment and Pharmacotherapy?The group starts by describing the sense of "enthusiasm" and "fulfillment" hepatology drug developers feel to see two drugs approved in the US and many other major changes to come (more drug approvals, FDA acceptance of a path to approval that is not based on liver biopsy). One interesting takeaway is that while the approval of semaglutide will likely change the number of patients treated with MASH pharmacotherapy, the greater impact of this approval will be on public awareness of MASH and the accompanying demand for treatment. In terms of actual drug use, the first major change will come among patients living with obesity but not Type 2 diabetes. Most of these patients previously saw their semaglutide prescriptions rejected for payment by health insurers. However, many of these patients will be living with MASH, and they are likely to see their prescriptions approved. Instead, the largest impact may involve increased education and awareness. Scott pointed out that endocrinologists, who frequently prescribe incretin agonists, will have reason to learn how to diagnose and manage MASH in patients they already treat. Zobair noted that an array of companies, starting with pharmaceutical manufacturers and scanning companies, will dramatically increase investments in prescriber and patient education.00:25:30 - Part II: How the Structure of Medical Practice Is Likely To ChangeNaim states that many hepatologists are currently uncomfortable managing patients on GLP-1 agonists. This will need to change. Manal points out that providers must check for cirrhosis when testing for MASH and understand how to respond accordingly. An increase in the number of providers having access to in-office scanning devices will facilitate this process. Zobair states that even if all related specialists integrate MASH into their practices, the actual patient care demand will require alternative pathways in which the responsibility for patient care will rest with specialist APPs. After Naim Alkhouri describes some of the differences between resmetirom and semaglutide in terms of practical treatment decisions, the discussion focuses on why MASLD and MASH will create unique challenges for hepatology practices. Manal views the issue as a matter of time; practices cannot absorb large numbers of new, non-urgent patients. Naim suggests that the real issue is the business question: specialists today do not profit simply from treating patients. Zobair agrees with Naim and notes that the challenge is not unique to hepatology. He expresses the hope that AI and efficient database management will make it easier to target patients, screen, diagnose and treat them. 00:44:17 - Part III: What Happens Next?In this final section, panelists identify some of the changes they foresee if we are to manage the tsunami of undiagnosed MASLD patients. Many of the comments touch on themes discussed earlier in this episode, but a couple are unique. Zobair states we must remember that the vast majority of MASLD patients will never develop MASH. Manal foresees a more sophisticated approach to selecting pharmacotherapies as prescribers have a broader set of options, each with its own benefits and drawbacks. Scotts anticipates a "paradigm shift" in which providers come to view MASH similarly to how they view diabetic comorbidities. 

On this podcast, I cover ciprofloxacin pharmacology. Ciprofloxacin is one of the most widely recognized fluoroquinolone antibiotics and has been on the market for decades. Because of its broad utility, it often comes up in practice, but it also carries significant adverse effect concerns and boxed warnings that pharmacists and prescribers need to keep in mind. From a pharmacology standpoint, ciprofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes that are essential for bacterial DNA replication, transcription, and repair. This action gives ciprofloxacin bactericidal activity against a variety of gram-negative organisms, including E. coli, Klebsiella, Enterobacter, and Pseudomonas aeruginosa. It also has some gram-positive activity, though it is generally not the best choice for strep infections. Ciprofloxacin comes in multiple dosage forms, including oral tablets, oral suspension, and intravenous formulations, which makes it flexible across care settings. I discuss the conversion of IV and PO formulations. Pharmacokinetics are important to consider. Ciprofloxacin is primarily renally eliminated, so dose adjustments are necessary in patients with impaired kidney function. Distribution into tissues is generally good, but it has limited activity in the lungs against Streptococcus pneumoniae, which is why it is not a first-line option for community-acquired pneumonia. Adverse effects are a major concern. The fluoroquinolone class carries multiple boxed warnings. Ciprofloxacin has been associated with tendon rupture, peripheral neuropathy, CNS effects such as agitation or seizures, and exacerbation of myasthenia gravis. More recent warnings include the risk for aortic aneurysm and hypoglycemia or hyperglycemia, particularly in older adults or those with comorbidities. On top of these boxed warnings, ciprofloxacin can also prolong the QT interval and cause GI upset. Drug interactions are another big factor in practice. Ciprofloxacin is a CYP1A2 inhibitor, which can raise levels of drugs like theophylline, tizanidine, and clozapine. It also interacts with polyvalent cations such as calcium, magnesium, iron, and aluminum, which can dramatically reduce its absorption—sometimes by more than 50%. This is a common reason for treatment failure if counseling isn't provided. From a dosing perspective, ciprofloxacin is usually given 250–750 mg orally twice daily or 400 mg IV every 8–12 hours depending on the indication and severity of infection. Renal dosing adjustments are needed as kidney function declines. In summary, ciprofloxacin is a powerful antibiotic when used appropriately. It remains an option for urinary tract infections, complicated intra-abdominal infections, and some cases of hospital-acquired pneumonia, but its use must be balanced with the potential for significant adverse effects and interactions. For pharmacists, educating patients on drug interactions, counseling about boxed warnings, and ensuring correct dosing in renal impairment are some of the most valuable interventions when ciprofloxacin shows up on a medication list.

See omnystudio.com/listener for privacy information.

Southwest Michigan's Morning News podcast is prepared and delivered by the WSJM Newsroom. For these stories and more, visit https://www.wsjm.com and follow us for updates on Facebook. See omnystudio.com/listener for privacy information.

Residents concerned with open air drug markets in and around parks

Join us this episode for a conversation with Norbert Weidner, MD, Professor and Chair of the Spinal Cord Injury Center at Heidelberg University Hospital. In this conversation we discuss results of a clinical trial called the Neuroimmunophilin Nogo-A Antibody in Spinal Cord Injury (NISCI) trial. Findings from this trial were published in a paper titled "Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trial" in the journal Lancet Neurology. In this paper Weidner and the NISCI team discuss the top-line findings from this large multi-center clinical trial where a drug (with antibodies against Nogo-A, a protein found in the walls of spinal cord neurons and their support cells) were given to people early after their accident. We invite you to listen in as Dr. Weidner gives an insider perspective on the NISCI trial, and trust you will enjoy our conversation on new pharmaology in the acute phase of SCI.

JPD Officer Aaron Gooch joined NewsTalk KZRG to discuss drugs in our community, and signs parents and grandparents should look out for to keep their kids safe from drugs. Join Ted, Steve, and Lucas for the KZRG Morning Newswatch!

REL-MAR McConnell Media Company – Transcript The ‘X' Zone Radio/TV Show – Thursday, August 28, 2025 Happy Retirement Gord - Segment 1- 00:00.00 – 06:23.385    “Here on The ‘X' Zone Radio Show, while we broadcast internationally to listeners across Canada, the United States, and around the world, right here on your Home Town Radio, Classic 1220  AM – CFAJ from our broadcast studios in St. Catharines, Ontario, it's important to take time to celebrate the people in our own community who make a lasting difference in our daily lives.  Today, we celebrate Gord, the manager of Shoppers Drug Mart at 125 Carlton Street here in St. Catharines, who is retiring after beginning his career with Shoppers Drug Mart back in 1978. Now, let's take a moment to remember what Canada looked like when Gord first put on his Shopper's Drug Mart badge.    In 1978, Pierre Elliott Trudeau was our Prime Minister.  The Toronto Blue Jays had just played their second Major League Baseball season.  Terry Fox was training quietly for what would become his heroic Marathon of Hope.  Anne Murray was topping the music charts, and Canadians were gathering around their TVs to watch Hockey Night in Canada, cheering on legends like Guy Lafleur and the Montreal Canadiens, who would go on to the Stanley Cup that year.  Through all those decades of Canadian history, Gord has been a constant with  kindness, professionalism, and a friendly smile at Shoppers Drug Mart.His leadership and dedication, along with the entire Shoppers team, have made that store a true pillar of the community.  On behalf of all the friendly and dedicated staff at Shoppers Drug Mart, the friends you have made, the customers that you have helped, everyone here at The ‘X' Zone Radio/TV Show, my wife Laura and myself, Gord, we all want to thank you.  Thank you for always being there for our family, and for families in St. Catharines that have met you, and have been customers at your Shoppers Drug Mart in the Lake and Carlton Plaza.  Gord, as you step into retirement after nearly half a century of service, we all wish you nothing but health, happiness, and well-earned relaxation.  Gord, congratulations on an extraordinary career — and thank you for being part of our lives since 1978.”Become a supporter of this podcast: https://www.spreaker.com/podcast/the-x-zone-radio-tv-show--1078348/support.Please note that all XZBN radio and/or television shows are Copyright © REL-MAR McConnell Meda Company, Niagara, Ontario, Canada – www.rel-mar.com. For more Episodes of this show and all shows produced, broadcasted and syndicated from REL-MAR McConell Media Company and The 'X' Zone Broadcast Network and the 'X' Zone TV Channell, visit www.xzbn.net. For programming, distribution, and syndication inquiries, email programming@xzbn.net.

Author Jacob Sullum joins Cam to discuss his new book Beyond Control: Drug Prohibition, Gun Regulation, and the Search for Sensible Alternatives.

William J. Federer is a nationally known speaker, historian, author, and president of Amerisearch, Inc. He is the speaker on "The American Minute" daily broadcast. Polls seem to show that Gen "Z" voters (age 18-29) are drawn to socialism and therefore it's this demographic that appears to be the source for the current popularity of candidates like Zohran Mamdani who is a New York State Assembly member running for mayor of New York. What's behind this appeal for socialism? William explained that there's two ways for people to give up their freedom: fear and free stuff. After WWII and the cold war, the communists couldn't defeat America from the outside so they tried doing it from the inside. It's the idea of making everyone dependent. He used the example of wild pigs. You put a post in the ground and throw some corn down. The pigs come and eat the corn and ignore the post. You keep adding posts and throwing down more and more corn. Eventually all you'll have left is a small opening for the pigs to enter the circle. The pigs will still squeeze their way in. Eventually, you shut the gate behind them and you've caught yourself some wild pigs. In other words, you've trapped them by dependency. Drug dealers use a similar approach in order to take over a neighborhood. They can cause fear by use of guns or they can be so nice that for a time they give away free drugs. They may do this until you are hooked at which point you are dependent upon the dealer as the source to supply your addiction. These examples are known as the Cloward-Piven Strategy, named after Richard Cloward and Frances Piven who were professors at Columbia University.

Connect with us on social media!Instagram | TikTok | Threads | Youtube | Facebook | X (Twitter) | WebsiteThis podcast offers health, fitness, and nutritional information and is designed for educational and entertainment purposes only. You should not rely on this information as a substitute for, nor does it replace professional medical advice, diagnosis, or treatment. If you have any concerns or questions about your health, you should always consult with a physician or other healthcare professional. Do not disregard, avoid, or delay obtaining medical or health-related advice from your healthcare professional because of something you may have heard on this podcast. The use of any information provided by Nacho Fitness Coach podcast is solely at your own risk.

William J. Federer is a nationally known speaker, historian, author, and president of Amerisearch, Inc. He is the speaker on "The American Minute" daily broadcast. Polls seem to show that Gen "Z" voters (age 18-29) are drawn to socialism and therefore it's this demographic that appears to be the source for the current popularity of candidates like Zohran Mamdani who is a New York State Assembly member running for mayor of New York. What's behind this appeal for socialism? William explained that there's two ways for people to give up their freedom: fear and free stuff. After WWII and the cold war, the communists couldn't defeat America from the outside so they tried doing it from the inside. It's the idea of making everyone dependent. He used the example of wild pigs. You put a post in the ground and throw some corn down. The pigs come and eat the corn and ignore the post. You keep adding posts and throwing down more and more corn. Eventually all you'll have left is a small opening for the pigs to enter the circle. The pigs will still squeeze their way in. Eventually, you shut the gate behind them and you've caught yourself some wild pigs. In other words, you've trapped them by dependency. Drug dealers use a similar approach in order to take over a neighborhood. They can cause fear by use of guns or they can be so nice that for a time they give away free drugs. They may do this until you are hooked at which point you are dependent upon the dealer as the source to supply your addiction. These examples are known as the Cloward-Piven Strategy, named after Richard Cloward and Frances Piven who were professors at Columbia University.

Extract from episode Spiderhead - What Goes Up Must Come DownAvailable on here and on YouTube

Professor Eamon Keenan, HSE National Clinical lead for addiction services, outlines the drug testing service which will run at Electric Picnic this weekend.

In this episode of Let's Combinate, Subhi Saadeh sits down with Jim Collins, a leader in drug delivery with over 30 years of experience at Eli Lilly, Sanofi, and now as an advisor and board member. Jim shares the history of combination products before the term even existed, from insulin pens in the 1990s to modern platforms and on-body injectors. We cover IP battles that reshaped the industry, supply chain risks that pharma still underestimates, and why platform strategy is one of the most important decisions a company can make today.Timestamps:00:00 – Introduction & Guest Welcome02:00 – Building Lilly's device organization and launching insulin pens06:00 – Early “wild west” days of drug delivery vs. today's structure07:00 – Intellectual property as a competitive weapon10:30 – How Lilly, Novo, and Sanofi shaped the IP landscape13:00 – Device differentiation in the generic space17:00 – Portfolio vs. molecule decisions in platform strategy20:00 – Three reasons to develop your own platform23:00 – Supply chain risk and geopolitical considerations26:00 – Black Swan risks and lessons for pharma companies28:00 – Strategic suppliers vs. transactional vendors33:00 – Drug-device integration inside companies37:00 – Building organizational capability and governance38:00 – Future trends: large volume autoinjectors and connected devices43:00 – Impact of tariffs and supply chain positioning45:00 – Where to find Jim CollinsGuest Bio:Jim Collins is a veteran of the drug delivery field with more than 30 years of leadership experience. At Eli Lilly, he built and led the device organization, overseeing the launch of insulin pens, the Forteo Pen, and the Trulicity platform. Later, at Sanofi, he led drug delivery innovation and platform development, including devices for Dupixent. Today, Jim serves as a board member for Enable Injections and advises startups, helping the next generation of innovators navigate IP, supply chain, and platform strategy.Subhi Bio:Subhi Saadeh is a Quality Professional and host of Let's Combinate. With a background in Quality, Manufacturing Operations, and R&D, he has worked in large medical device and pharma organizations to support the development and launch of hardware devices, disposable devices, and combination products for vaccines, generics, and biologics. Subhi serves as International Committee Chair for the Combination Products Coalition (CPC), as a member of ASTM Committee E55, and previously on AAMI's Combination Products Committee. For questions, inquiries, or suggestions, visit letscombinate.com or connect on LinkedIn.

Israel's security cabinet is set to meet amid nationwide protests. Jeffrey Epstein's 50th “birthday book” is among the documents the House Oversight committee are subpoenaing. Thousands more documents are set to be released related to the Uvalde school shooting three years ago. Firefighters are winning the battle against two wildfires in the West of the country. Plus, the US Coast Guard's historic drug bust. Learn more about your ad choices. Visit podcastchoices.com/adchoices

We've got an important update on a diabetes drug you may have never heard about. Sotagliflozin is known to have big benefits for people with type 2 but getting it approved for type 1 has been frustrating to say the least. The FDA has twice declined to approve it for people with T1D, but experts – including my guest – are pushing and hoping that will soon change. I'm talking to Dr. Steve Edleman, an endocrinologist who lives with type 1 and heads up the group Take Control of Your Diabetes – TCOYD. We'll talk about the risks that come with sotogliflozin, how continuous ketone monitoring could change the game, and what you can do to push for change. TCOYD's petition here This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Join us at an upcoming Moms' Night Out event! Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

Markets saw a melt-up near the end of Tuesday's session that pushed indices solidly into green territory. This comes despite comments from President Trump saying he plans to fire Fed governor Lisa Cook. As for the session gainers, Eli Lilly (LLY) rallied strongly after posting breakthrough results for its obesity drug trial, as did MongoDB (MDB) for showing strong earnings and raised guidance. Sam Vadas takes investors through the day's biggest stories.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

AT&T (T) secured a deal worth $23 billion with EchoStar (SATS) to buy spectrum licenses from the company. Eli Lilly (LLY) tacked on billions of dollars in market share after its experimental weight loss pill showed promise in its latest trial results. Three analysts dressed up Ulta Beauty (ULTA) price targets as they see a bounce back in the company. Diane King Hall discusses what's driving the biggest market moves Tuesday morning.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

Send us a textWe all know movement is good for us. But can the right kind of exercise actually slow the aging process itself?In this episode, Dr. Kevin White talks with Benjamin Miller, Ph.D., professor of aging research at OMRF and past president of the American Aging Association, about what really happens to our muscles and mitochondria as we age, and how his new NIH-funded clinical trial is working to answer one of the most important questions in longevity science: why do some people respond to exercise better than others?"Every drug we study is just trying to be as good as exercise — and exercise still wins."Dr. Miller explains the biology of aging in plain language, from protein damage to energy production, and shares why exercise still outperforms any “miracle drug” on the market. He also unpacks the design of his new trial, where people 60 and older will receive supervised training, advanced health testing, and wearables to measure everything from VO₂ max to sleep — all with the goal of predicting who benefits most from which type of exercise.In this episode:Why exercise is still the closest thing we have to a longevity drugHow mitochondria and protein health drive resilience as we ageWhat VO₂ max actually measures — and why it predicts lifespanThe role of genetics vs. lifestyle in how our bodies respond to trainingHow to get involved in Dr. Miller's NIH-backed exercise study at OMRFThis conversation is a reminder that slowing aging isn't about hacks or shortcuts — it's about moving, staying engaged, and using science to make every decade stronger than the last. Prime Health Associates

From RCAF Patrol Missions to Counter-Drug and SAR Operations in the CaribbeanWhat kinds of missions do a long-range patrol sensor operator and crew commander face in the Royal Canadian Air Force (RCAF)? What challenges and close calls have they experienced, and how did those skills carry over into high-stakes counter-narcotics and Search and Rescue (SAR) missions in the Caribbean?In this episode, retired RCAF Lieutenant-Colonel Trevor Juby, now Chief Pilot with Provincial Airlines / PAL Aerospace in Curaçao, and retired RCAF Master Warrant Officer Pat Lalande, now a tactical coordinator and mission commander with PAL Aerospace, share their journey from Canadian military aviation to today's critical counter-drug and SAR operations.Listeners will hear about their careers in the RCAF, the transition to international aviation operations, and the realities of flying missions in one of the most complex and dynamic regions of the world.

As you may have heard, AI-designed medicines have crossed a historic line. In this episode, Alex Zhavoronkov - CEO of Insilico Medicine and founder of ARDD walks us through how Insilico's rentosertib became the first AI-generated small molecule with peer-reviewed clinical efficacy, while arguing against AI hype and reminding us that biology still moves at “the speed of traffic.” That duality runs through the whole conversation. On one side: a pragmatic operator obsessed with credible science, biomarkers, and clinical benchmarks; on the other: an AI visionary investing in cryonics, sketching “pharmaceutical superintelligence,” and thinking in decades, not quarters.We start in Basel, home to Roche and Novartis, where ARDD was born, then trace how the conference morphed into a ”high-signal filter for longevity” - packed with startups (who also fund it), hard data, and mainstream pharma.Alex looks back at his 2014 Nvidia talk (”Can Nvidia solve aging?”) and explains why Insilico trains its AI to learn age first - so it actually grasps biology. Years of problem-solving with pharma turned into their Pharma.AI toolkit (Biology42, Chemistry42, Medicine42, Science42).Insilico now runs 40+ programs and in an early Phase 2 study for idiopathic pulmonary fibrosis (IPF), their drug rentosertib showed a dose-dependent boost in lung capacity.Compared with the old path - often $150–200M and ~5 years just to pick a lead molecule - Insilico says it can often reach that point for under $3M or even less. Still, Alex is cautious: no matter how smart the AI gets, real-world testing and regulation won't speed up overnight.Also in this episode:What made Alex cry.Why he wouldn't give his own drug to patients - yet.How a mirror on a conference poster led to a proposal.How ARDD became the “WEF of longevity”.Why internal “kill teams” try to stop their own drug candidates.Why labeling aging a disease helps - but won't shortcut approvals.Why he writes to “feed AI”.How Nvidia threads through the story - from free GPUs to Jensen's video.

Dr. Michael Lynch, Associate Professor of Emergency Medicine and Medical Toxicology at the University of Pittsburgh and an attending physician at UPMC, calls in to wan listeners of a new street drug called Flyskyy.

[01:02:09] Conservatives Back Martial LawOpening monologue criticizes conservatives for supporting Trump's talk of deploying troops in U.S. cities, linking it to the Pentagon's long-term planning for urban control. [01:05:31] Prohibition, Cartels & TerrorComparison of alcohol prohibition to the drug war; warns that attacking Mexican cartels militarily could spark terrorism inside American cities and provide cover for martial law. [01:12:29] Election Rigging & GerrymanderingDiscussion of how both parties manipulate elections through gerrymandering and voting controls; frames Trump as a Pentagon puppet in a larger plan of urban militarization. [01:20:48] Conservatives Cheer MilitarizationChicago carjacking victim opposed National Guard deployment; conservatives attacked her online, showing how Trump has shifted the right to embrace authoritarian solutions. [01:29:46] Normalizing Martial LawAnalysis of how deploying troops in D.C. and other cities is “predictive programming” to normalize military presence and condition officials and citizens for broader martial law. [01:45:21] Democrats Only OppositionClosing reflections argue conservatives have abandoned constitutional limits, leaving only Democrats to oppose Trump's martial law plans—though they oppose for the wrong reasons, focusing only on partisan power. [02:19:39] Texas “Big Beautiful Map” & Election RiggingDiscussion of Texas Senate passing a gerrymandered redistricting bill, Trump pushing to ban mail-in ballots and voting machines, and how both parties manipulate elections. [02:32:18] CDC Launches Vaccine Injury ReviewCriticism of the CDC forming a group to investigate COVID vaccine injuries, framed as a whitewash to protect Trump's Operation Warp Speed and Big Pharma. [02:36:04] Genetic Code Injections & Aluminum RisksSegment highlights concerns over mRNA shots replicating uncontrollably and reviews studies linking aluminum adjuvants to asthma, autism, and SIDS. [02:43:09] Hypervaccination Horror StoriesPersonal accounts of children permanently damaged after “catch-up” vaccine schedules in custody battles; broader attack on CDC and medical industry dishonesty. [02:49:41] Bioweapon Narrative & Military OperationDiscussion frames COVID vaccination as a Pentagon/DARPA military operation, not medicine, with secrecy and top-secret clearances tied to bio-surveillance. [03:08:15] Bayer, Monsanto & Legal ImmunityDeep dive into Monsanto's history with Agent Orange, PCBs, Roundup, GMOs, and Bayer's Nazi past; warnings that Trump and RFK Jr. are paving the way for legal immunity for “Big Pest.” [03:30:29] Greenland Child Seizures & Parenting TestsCase of a Greenlandic mother losing her baby under “parenting competence tests,” framed as government overreach tied to globalist family-erasure agendas. [03:35:02] Miraculous Cardiac RecoveryTeen athlete suffers sudden cardiac arrest and survives after 30 minutes without a heartbeat, presented as both a vaccine injury suspicion and a story of prayer and divine healing. [03:38:13] Legacy of James DobsonReflection on the life and influence of James Dobson—praised for defending families but criticized for Zionism and naïve trust in government institutions. Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silverFor 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHTFind out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

[01:02:09] Conservatives Back Martial LawOpening monologue criticizes conservatives for supporting Trump's talk of deploying troops in U.S. cities, linking it to the Pentagon's long-term planning for urban control. [01:05:31] Prohibition, Cartels & TerrorComparison of alcohol prohibition to the drug war; warns that attacking Mexican cartels militarily could spark terrorism inside American cities and provide cover for martial law. [01:12:29] Election Rigging & GerrymanderingDiscussion of how both parties manipulate elections through gerrymandering and voting controls; frames Trump as a Pentagon puppet in a larger plan of urban militarization. [01:20:48] Conservatives Cheer MilitarizationChicago carjacking victim opposed National Guard deployment; conservatives attacked her online, showing how Trump has shifted the right to embrace authoritarian solutions. [01:29:46] Normalizing Martial LawAnalysis of how deploying troops in D.C. and other cities is “predictive programming” to normalize military presence and condition officials and citizens for broader martial law. [01:45:21] Democrats Only OppositionClosing reflections argue conservatives have abandoned constitutional limits, leaving only Democrats to oppose Trump's martial law plans—though they oppose for the wrong reasons, focusing only on partisan power. [02:19:39] Texas “Big Beautiful Map” & Election RiggingDiscussion of Texas Senate passing a gerrymandered redistricting bill, Trump pushing to ban mail-in ballots and voting machines, and how both parties manipulate elections. [02:32:18] CDC Launches Vaccine Injury ReviewCriticism of the CDC forming a group to investigate COVID vaccine injuries, framed as a whitewash to protect Trump's Operation Warp Speed and Big Pharma. [02:36:04] Genetic Code Injections & Aluminum RisksSegment highlights concerns over mRNA shots replicating uncontrollably and reviews studies linking aluminum adjuvants to asthma, autism, and SIDS. [02:43:09] Hypervaccination Horror StoriesPersonal accounts of children permanently damaged after “catch-up” vaccine schedules in custody battles; broader attack on CDC and medical industry dishonesty. [02:49:41] Bioweapon Narrative & Military OperationDiscussion frames COVID vaccination as a Pentagon/DARPA military operation, not medicine, with secrecy and top-secret clearances tied to bio-surveillance. [03:08:15] Bayer, Monsanto & Legal ImmunityDeep dive into Monsanto's history with Agent Orange, PCBs, Roundup, GMOs, and Bayer's Nazi past; warnings that Trump and RFK Jr. are paving the way for legal immunity for “Big Pest.” [03:30:29] Greenland Child Seizures & Parenting TestsCase of a Greenlandic mother losing her baby under “parenting competence tests,” framed as government overreach tied to globalist family-erasure agendas. [03:35:02] Miraculous Cardiac RecoveryTeen athlete suffers sudden cardiac arrest and survives after 30 minutes without a heartbeat, presented as both a vaccine injury suspicion and a story of prayer and divine healing. [03:38:13] Legacy of James DobsonReflection on the life and influence of James Dobson—praised for defending families but criticized for Zionism and naïve trust in government institutions. Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silverFor 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHTFind out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.

To rugby league, and an investigation by Queensland police has resulted in Kiwis international Brandon Smith being charged with drug and betting offences. Sydney Morning Herald chief rugby league reporter Adrian Proszenko spoke to Corin Dann.

Send us a textChapters:[00:00] Introduction: The Two Competing NarrativesThe video opens by posing the central question: Is rescheduling cannabis to Schedule 3 a victory for the industry or a deceptive political trap? The host introduces the two extreme viewpoints—one of political grandstanding and the other of a "Big Pharma" takeover.[01:07] Understanding Schedule 1: "Maximum Security Prison for Substances"This section explains the current, restrictive classification of cannabis.What is Schedule 1? It's the most restrictive category for drugs with "no currently accepted medical use and a high potential for abuse," placing cannabis in the same category as heroin.The Absurdity: The host points out that this classification is scientifically dishonest, as the federal government considers cannabis more dangerous than cocaine or ketamine (Schedule 2).[01:52] The Push for Rescheduling: A "Monumental Step"The discussion shifts to the Biden administration's move to re-evaluate cannabis scheduling.[02:48] The "Win" Scenario: Potential Positive ImpactsThis chapter explores the benefits that advocates for rescheduling are highlighting.Reducing Stigma: A federal acknowledgment of medical value would help destigmatize cannabis use.Boosting Research: Universities would be less fearful of losing federal funding, potentially leading to a new "golden age" of medical cannabis research.Major Tax Relief: The most significant impact would be the elimination of the 280E tax code, which currently prevents cannabis businesses from taking normal deductions. This could be a massive financial lifeline for the industry.[03:30] The "Scam" Scenario: A Trojan Horse for Big Pharma?Here, the video presents the counter-argument from skeptics.Prescription-Only Panic: The core fear is that Schedule 3 makes cannabis a prescription drug, potentially rendering thousands of state-legal dispensaries illegal overnight.FDA Takeover: This narrative suggests the move is a ploy to hand control of the entire industry to the FDA and large pharmaceutical companies.[05:28] The Truth Is in the Middle: It's Just PoliticsThe host argues that both extreme narratives are overblown.Not a Win, Not a Scam: The reality is a complex bureaucratic shuffle, not a final victory or a hostile takeover.Kicking the Can to Congress: Rescheduling is a way for politicians to appear proactive while leaving the fundamental legal conflicts for Congress to resolve.[06:22] The Real-World Changes (and What Stays the Same)This section breaks down the three most tangible impacts of rescheduling.Symbolic Victory: A landmark shift in federal perspective.Tax Relief (280E): The most powerful, immediate change for businesses.The Legal Conflict Continues: The state vs. federal law conflict remains, and dispensaries are still not compliant with the Food, Drug, and Cosmetic Act (FDCA) without FDA approval.[08:06] The Bottom Line: The Fight Isn't OverThe video concludes by emphasizing that this move is political theater. True, lasting change for cannabis freedom requires legislative action from Congress to create a clear, legal framework for the industry to operate within.[09:25] Call to Action & Final ThoughtsThe host encourages viewers to stay informed, like and share the video, and check out another video detailiSupport the showGet our newsletter: https://bit.ly/3VEn9vu

The week in whacky, plus a Mustachioed Chump Line!  Visit the Howie Carr Radio Network website to access columns, podcasts, and other exclusive content.

See omnystudio.com/listener for privacy information.

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from August 16-22 2025.

In this episode, I update you on my family, my business, my podcasts (2), and what I've been listening to, reading, watching, and playing this Summer.   Thank you for listening to episode 344 of The Pharmacist's Voice ® Podcast!   To read the FULL show notes, visit https://www.thepharmacistsvoice.com. Click the podcast tab, and select episode 344.   Host background (August 2025) My name is Kim Newlove, and I'm an Ohio-licensed pharmacist. I graduated from The University of Toledo College of Pharmacy with my BS Pharm in 2001. I have experience in hospital, retail, compounding, and behavioral health. I'm not in clinical practice anymore. Instead, I use my voice to write, narrate, and podcast—and I draw on that experience to help others share their own voices through spoken and written content.   Subscribe to or follow The Pharmacist's Voice ® Podcast to get each new episode delivered to your podcast player and YouTube every time a new one comes out!     Apple Podcasts   https://apple.co/42yqXOG  Spotify  https://spoti.fi/3qAk3uY  Amazon/Audible  https://adbl.co/43tM45P YouTube https://bit.ly/43Rnrjt   Family update Kraig's graduation party was at home on June 28th.  Derrick starts his 3rd year at The University of Cincinnati this Fall. He is majoring in Business Analytics. Nathan turned 50 in June. He's looking forward to adopting a Labradoodle this month.  As a family, we have been doing summer things, like grilling, riding bikes, going to the Farmers Market in town, visiting ice cream shops, and more. Nathan and I celebrated our 24th wedding anniversary in June, and I celebrated my 47th birthday in July. Our backyard remodeling project is finally done! We went from wooden deck to concrete patio and operable pergola.   Business update — The Pharmacist's Voice, LLC ⭐️I just renewed my pharmacist license.  ⭐️My monthly newsletter is going strong. Click to sign up today. https://bit.ly/3AHJIaF  ⭐️I am teaching Podcasting 101 and Audio Engineering 101 for Podcasters at the 577 Foundation in Perrysburg, OH in September 2025. https://577foundation.org/  ⭐️I will update my website in 2026 to reflect the services I offer. ⭐️I have room for two new clients (August 2025). Contact me through my website.  I help people start and produce podcasts. I help authors narrate audiobooks. I help people from all walks of life say drug names correctly. I moderate CE sessions at conferences at “doctor conferences”  I'd like to record some legacy interviews in 2026. I still plan to host both of my podcasts, too.   The Pharmacist's Voice Podcast - Update   The Pharmacist's Voice Podcast is still going strong. We're on episode 344 today, and I plan to continue publishing weekly episodes until January 2026. At that point, I'll switch to a monthly schedule. In today's episode, I summarize the episodes I published this summer.   The Perrysburg Podcast (my local podcast) — Update   The Perrysburg Podcast is a resource for Perrysburg residents. We talk about what's in Perrysburg and why people like to live here. It's a 3-year service project I started for the town where I live. The website is perrysburgpodcast.com. I'm in the last year of producing weekly episodes, and the podcast is scheduled to end on July 3, 2026. In this episode, I summarized the episodes I published this summer.   Thank you to Frank Racioppi for nominating The Perrysburg Podcast for Best Local Podcast in the 2025 Ear Worthy Awards. Frank runs a blog called Ear Worthy. Click to read the blog. https://medium.com/ear-worthy/announcing-the-nominees-for-the-ear-worthy-awards-049723d052c9    What have I been listening to?  Music - I added some Coldplay songs to my favorite playlist. Podcasts - The School of Podcasting Podcast, The Collective RX Podcast,  The Diabetes Remission Roadmap Podcast, and Episode 283 of The Pharmacist's Voice Podcast Audiobooks - How to be a Patient by Sana Goldberg and The Brain That Changes Itself by Dr. Norman Doidge, MD   What have I been reading? I read printed books with Kraig almost daily. Three examples are: The Spy School Series by Stuart Gibbs 20 Years of Internet Humor by Bill Williams Dragons Love Tacos by Adam Rubin   What have I been watching? Modern Family (TV Series) Survivor (Reality TV Show) The Good Place (TV Series)  Deep Fake (Movie)  The Pick Up Zootopia (Movie)   What have I been playing? Ticket to Ride Board Game Euphoria Board Game    If you know someone who might like this episode, please share it with them.    Previous Updates on this podcast Episode 331 Spring 2025 Update Episode 319 Winter 2025 Update Episode 305 Fall 2024 Update Episode 291 Summer 2024 Update Episode 279 Spring 2024 Update Episode 264 Winter 2024 Update  Episode 252 Fall 2023 Update Episode 238 Summer 2023 Update Episode 217 Spring 2023 Update Episode 200 Winter 2023 Update Episode 186 Fall 2022 Update   Kim's websites and social media links: ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF  ✅ LinkedIn Newsletter link https://bit.ly/40VmV5B ✅ Business website https://www.thepharmacistsvoice.com ✅ Buy my book on amazon.com https://amzn.to/4iAKNBs  ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Drug pronunciation course https://www.kimnewlove.com ✅ A Behind-the-scenes look at The Pharmacist's Voice ® Podcast © Online Course https://www.kimnewlove.com  ✅ LinkedIn https://www.linkedin.com/in/kimnewlove ✅ Facebook https://www.facebook.com/kim.newlove.96 ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z ✅ Start a podcast with the same coach who helped me get started (Dave Jackson from The School of Podcasting)! **Affiliate Link - NEW 9-8-23**      Thank you for listening to episode 344 of The Pharmacist's Voice ® Podcast. If you know someone who would like this episode, please share it with them!

Dr. Kelly Victory, Chief of Disaster & Emergency Medicine at The Wellness Company, joins the show to discuss urgent issues in health and preparedness. She weighs in on President Trump's proposal to levy tariffs on imported prescription drugs to push manufacturing back to the U.S., explaining whether it's a good idea, what challenges it could bring, and how it may impact Americans. Dr. Victory also shares practical advice on whether Americans should consider stockpiling critical medications, the safest way to do so, and what families should know as kids head back to school and infection rates begin to climb again.   Visit twc.health/GRUBER, promo code: GRUBER

A researcher uncovers vulnerabilities across Intel's internal websites that exposed sensitive employee and supplier data. The Kimsuky group (APT43) targets South Korean diplomatic missions. A new DDoS vulnerability bypasses the 2023 “Rapid Reset” fix. Drug development firm Inotiv reports a ransomware attack to the SEC. The UK drops their demand that Apple provide access to encrypted iCloud accounts. Hackers disguise the PipeMagic backdoor as a fake ChatGPT desktop app. The source code for a powerful Android banking trojan was leaked online. A Nebraska man is sentenced to prison for defrauding cloud providers to mine nearly $1 million in cryptocurrency. On this week's Threat Vector, David Moulton speaks with Liz Pinder and Patrick Bayle for a no holds barred look at context switching in the SOC. A UK police force fails to call for backup. Remember to leave us a 5-star rating and review in your favorite podcast app. Miss an episode? Sign-up for our daily intelligence roundup, Daily Briefing, and you'll never miss a beat. And be sure to follow CyberWire Daily on LinkedIn. Threat Vector Security analysts are drowning in tools, alerts, and tabs. On today's Threat Vector segment from Palo Alto Networks, we offer a snapshot from host⁠ David Moulton⁠'s conversation with⁠ Liz Pinder⁠ and⁠ Patrick Bayle⁠⁠. Together they take a no holds barred look at context switching in the SOC, what it costs, why it's getting worse, and how smarter design can fix it. You can listen to David, Patrick, and Liz's conversation⁠ here⁠. It's a must-listen for anyone building or managing a modern SOC. New episodes of⁠ Threat Vector⁠ drop each Thursday on the N2K CyberWire network and in your favorite podcast app. Selected Reading Intel data breach: employee data could be accessed via API (Techzine Global) North Korean Kimsuky Hackers Use GitHub to Target Foreign Embassies with XenoRAT Malware (GB Hackers) Internet-wide Vulnerability Enables Giant DDoS Attacks (Dark Reading) Drug development company Inotiv reports ransomware attack to SEC (The Record) UK ‘agrees to drop' demand over Apple iCloud encryption, US intelligence head claims (The Record) Ransomware gang masking PipeMagic backdoor as ChatGPT desktop app: Microsoft (The Record) ERMAC Android malware source code leak exposes banking trojan infrastructure (Bleeping Computer) Nebraska man gets 1 year in prison for $3.5M cryptojacking scheme (Bleeping Computer) South Yorkshire Police Deletes 96,000 Pieces of Digital Evidence  (Infosecurity Magazine) Audience Survey Complete our annual audience survey before August 31. Want to hear your company in the show? You too can reach the most influential leaders and operators in the industry. Here's our media kit. Contact us at cyberwire@n2k.com to request more info. The CyberWire is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today's “Skip Bayless Show”: Why Jerry's remark to Micah sent me over the edge … MICHAEL IRVIN UNLOADS ABOUT HIS DRUG-FUELED PAST … Dillon Gabriel vs Shedeur … Eagles WAY BETTER THAN Cowboys … Why Ashton Jeanty might not last … Kelsey vs Caitlin Learn more about your ad choices. Visit podcastchoices.com/adchoices

NAC (N-acetylcysteine) in kids -Vitamin D for sunburn - Imiquimod for PGs -How to prevent bone issues in patients on steroids - Cutaneous extramedullary plasmacytoma -DRESS by drug -Learn more about the U of U Dermatology ECHO model!physicians.utah.edu/echo/dermatology-primarycareWant to donate to the cause? Do so here!
Donate to the podcast: uofuhealth.org/dermasphere
Check out our video content on YouTube:
www.youtube.com/@dermaspherepodcast
and VuMedi!: www.vumedi.com/channel/dermasphere/
The University of Utah's Dermatology
ECHO: ⁠physicians.utah.edu/echo/dermatology-primarycare -
⁠ Connect with us!
- Web: ⁠dermaspherepodcast.com/⁠ - Twitter: @DermaspherePC
- Instagram: dermaspherepodcast
- Facebook: www.facebook.com/DermaspherePodcast/
- Check out Luke and Michelle's other podcast,
SkinCast! ⁠healthcare.utah.edu/dermatology/skincast/⁠ Luke and Michelle report no significant conflicts of interest… BUT check out our
friends at:
- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)
- ⁠www.levelex.com/games/top-derm⁠ (A free dermatology game to learn
more dermatology!

From flying cocaine-laden planes to running massive boat shipments, Luis Navia was a logistics mastermind for the Medellín Cartel — responsible for moving over 100 tons of cocaine into the U.S. and Europe. In this gripping full-length interview, Luis pulls back the curtain on a 25-year career that spanned the height of the cocaine boom, working alongside legendary traffickers like Pablo Escobar. - Surviving kidnappings & near-death experiences in the drug trade - The cartel's control over coca production in Peru - The evolution of smuggling methods — from air to sea - How a mole inside the organization led to his capture - Life after prison & his book Pure Narco Now a construction company owner in Miami, Luis reflects on his Cuban heritage, the dangers of the cartel world, and the lessons learned from a life on the run.

In episode 1915, Miles and guest co-host Pallavi Gunalan are joined by co-host of Secretly Incredibly Fascinating, Alex Schmidt, to discuss… DC Is So Unsafe! McDonald’s Latest Nostalgia Bait Meal Is A Rip Off In More Ways Than One and more! Benny Johnson on Washington, DC: “Entire neighborhoods, probably, need to be emptied, need to be bulldozed” Republican Senator Says He Doesn’t Wear Seatbelt in D.C. Because He Fears Being Carjacked: ‘I Don’t Buckle Up’ What are people doing with the Grimace shake? Here's the TikTok trend explained. Grimace Brought Big Sales Growth To McDonald's Fans Are Sharing Shocking Prices Of McDonald's New McDonaldland Meal In Their Towns I Tried the Mt. McDonaldland Shake to Figure Out the Mystery Flavor Step Inside McDonaldland VR: A Bold New Immersive World Featuring Grimace, Ronald McDonald, and Friends McDisney: The history of two unlikely forces Remembering The Forgotten Titans Of McDonaldland LISTEN: Riendo Con Cha Cha by La Playa SextetSee omnystudio.com/listener for privacy information.

Lights Out Merch: https://milehighermerch.com/ Higher Hope Foundation: https://higherhope.org Follow & Subscribe To The Show! Spotify: https://open.spotify.com/show/3SfSNbkVrfz3ceXmNr0lZ4 Apple Podcasts: https://podcasts.apple.com/us/podcast/lights-out/id1505843600 Social Links: TikTok: https://www.tiktok.com/@lightsoutcast Twitter: http://twitter.com/lightsoutcast Instagram: http://instagram.com/lightsoutcast Suggestions/Comments: lop@milehigher.com Merch: https://lightsoutcast.shop/ Request A Topic Form: https://docs.google.com/forms/d/e/1FAIpQLSeOikdybNMOzpHIjLy0My2fYF0LXgN3NXDC0BQNFNNSXjetpg/viewform?usp=sharing Podcast sponsor inquires: adops@audioboom.com Host: Josh Twitter: http://twitter.com/milehigherjosh Instagram: http://instagram.com/milehigherjosh Writer/Co-host: Austin Instagram: https://www.instagram.com/austin_leee_/ Editor/Producer: Daniel Instagram: https://www.instagram.com/horrororeo Creator hosts a documentary series for educational purposes (EDSA). These include authoritative sources such as interviews, newspaper articles and TV news reporting meant to educate and memorialize notable cases in our history. Videos come with editorial context added bolstering educational and artistic value. Please review at your leisure. Sources:  https://pastebin.com/XbBwEwBh